Your browser doesn't support javascript.
loading
Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials.
Huang, Yanrong; Fan, Yong; Liu, Yang; Xie, Wenhui; Zhang, Zhuoli.
Afiliação
  • Huang Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China.
  • Fan Y; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China.
  • Liu Y; Department of Orthopedics, Clinical Sciences, Lund University, 22185, Lund, Sweden.
  • Xie W; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China.
  • Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China. zhuoli.zhang@126.com.
Clin Rheumatol ; 38(10): 2765-2776, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31087226

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Anticorpos Monoclonais Humanizados / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Clin Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Anticorpos Monoclonais Humanizados / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Clin Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China